Targeting Inflammation in CVD: Lessons From ZEUS and the Potential of NLRP3 Inhibition

Explore the role of inflammation in CVD, insights from the ZEUS trial, and the rationale for targeting the upstream NLRP3 inflammasome.

ReachMD Healthcare Image
Register

We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?

Register for free